trending Market Intelligence /marketintelligence/en/news-insights/trending/n2XU4ytBlYJCbLehEBfB5Q2 content esgSubNav
In This List

PureTech Health appoints chief medical officer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


PureTech Health appoints chief medical officer

PureTech Health PLC appointed Atul Pande as its chief medical officer.

Pande, a psychiatrist by profession, will oversee all clinical operations across PureTech Health's pipeline, which include therapies targeting the immune, nervous and gastrointestinal systems.

Pande serves on the board of PureTech unit Karuna Pharmaceuticals. He is also a director of Axovant Sciences Ltd.